biophBiomedical PhotonicsBiomedical Photonics2413-9432Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis10.24931/2413-9432-2019-8-2-31-46bioph-317Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSСонодинамическая и соно-фотодинамическая терапия в онкологииSonodynamic and sono-photodynamic therapy in oncologyЦерковскийД. А.TzerkovskyD. A.tzerkovsky@mail.ruПротоповичЕ. Л.ProtopovichE. L.СтупакД. С.StupakD. S.Республиканский научно-практический центр онкологии и медицинской радиологии им. Н.Н. АлександроваБеларусьN.N. Alexandrov National Cancer Centre of BelarusBelarus201910072019823146Copyright © Церковский Д.А., Протопович Е.Л., Ступак Д.С., 20192019Церковский Д.А., Протопович Е.Л., Ступак Д.С.Tzerkovsky D.A., Protopovich E.L., Stupak D.S.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pdt-journal.com/jour/article/view/317

В представляемой публикации авторами произведен анализ результатов применения сонодинамической и соно-фотодинамической терапии с фотосенсибилизирующими агентами различных классов (гематопорфирин, 5-аминолевулиновая кислота, производные хлорина и др.) в экспериментальных исследованиях и клинической онкологии. В ряде in vitro и in vivo исследований доказана высокая противоопухолевая эффективность указанных выше методов лечения. Ультразвуковое воздействие с частотой импульсов 1–3 МГц и интенсивностью от 0,7 до 5 Вт/см2 в отдельности и в комбинации с фотооблучением экспериментальных опухолей, позволяет существенно повысить эффективность лечения. Это стало основой для апробации методов у пациентов со злокачественными новообразованиями различных локализаций. Учеными из стран Юго-Восточной Азии представлены предварительные результаты применения сонодинамической и соно-фотодинамической терапии с фотосенсибилизаторами в лечении злокачественной патологии молочной железы, желудка, пищевода, предстательной железы, легкого и головного мозга. Анализ полученных данных свидетельствует об отсутствии серьезных нежелательных явлений и повышении противоопухолевой эффективности лечения, в которое были включены данные методы лечения с фотосенсибилизаторами хлоринового ряда. 

In the present publication, authors have analyzed the results of using sonodynamic and sono-photodynamic therapy with photosensitizing agents of various classes (hematoporphyrin, 5-aminolevulinic acid, chlorin derivatives, etc.) in experimental oncology. In a number of in vitro and in vivo studies, the high antitumor efficacy of the above treatment methods has been proven. Ultrasonic treatment with a pulse frequency of 1–3 MHz and an intensity of 0.7 to 5 W/cm2 , independently and in combination with photo-irradiation of experimental tumors, can significantly improve the cytotoxic properties of photosensitizers. This became the basisfor testing the methodsin patients with malignant neoplasms of various localizations. Scientists fromSouth-East Asia presented the preliminary results of the use of sonodynamic and sono-photodynamic therapy with photosensitizers in the treatment of malignant pathology of the mammary gland, stomach, esophagus, prostate, lung and brain. Analysis of the obtained data indicates the absence of serious adverse events and an increase in the antitumor efficacy of treatment, which included these treatment methods with chlorin-type photosensitizers. 

сонодинамическая терапиясоно-фотодинамическая терапияфотосенсибилизаторызлокачественные новообразованияReferencesEscoffre J.M. and Bouakaz A.B. Therapeutic ultrasound. – Switzerland: Springer, 2016. – 459 p.Escoffre J.M. and Bouakaz A.B. Therapeutic ultrasound. Switzerland, Springer, 2016. 459 p.Улащик В.С., Чиркин А.А. Ультразвуковая терапия.– Минск : Издательство «Беларусь», 1983. – 254 с.Ulashchik V.S., Chirkin A.A. Ultrazvukovaya terapiya [Ultrasound therapy].Minsk, Belarus Publ., 1983. 254 p.Couture O., Foley J., Kassel N.F., et al. Review of ultrasound mediated drug delivery for cancer treatment: updates from pre-clinical studies // Transl. Cancer Res. – 2014. – Vol. 3, No. 5. – P. 494–511.Couture O., Foley J., Kassel N.F., Larrat B., Aubry J.-F. Review of ultrasound mediated drug delivery for cancer treatment: updates from pre-clinical studies, Transl. Cancer Res., 2014, vol. 3, no. 5, pp. 494–511.Costley D., McEwan C., Fowleym C., et al. Treating cancer with sonodynamic therapy: A review // Int. J. Hyperthermia. – 2015. – Vol. 32, No. 2. – P. 107–117.Costley D., McEwan C., Fowleym C., McHale A.P., Atchison J., Nomikou N., Callan J.F. Treating cancer with sonodynamic therapy: A review,Int. J. Hyperthermia, 2015, vol. 32, no. 2, pp. 107–117.Nikolaev A.L., Gopin A.V., Bozhevolnov V.E., et al. Combined method of ultrasound therapy of oncological diseases // Rus. J.Gen. Chem. – 2015. – Vol. 85, No. 1. – P. 303–320.Nikolaev A.L., Gopin A.V., Bozhevolnov V.E., Treshalina H.M., Andronova N.V., Melikhov I.V., Filonenko E.V., Mazina S.E., Gerasimova G.K., Khorosheva E.V., Mikhailova I.N., Demidov L.V., Bokhyan B.Yu., Kogan B.Ya., Kaliya O.L. Combined method of ultrasound therapy of oncological diseases, Rus. J.Gen. Chem., 2015, vol. 85, no. 1, pp. 303–320.Liu X. H., Li S., Wang M., Dai Z.J. Current status and future perspectives of sonodynamic therapy and sonosensitiers // Asian Pac. J. Cancer Prev. – 2015. – Vol. 16, No. 11. – P. 4489–4492.Liu X. H., Li S., Wang M., Dai Z.J. Current status and future perspectives of sonodynamic therapy and sonosensitiers, Asian Pac. J. Cancer Prev., 2015, vol. 16, no. 11, pp. 4489–4492.Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy – a review of the synergistic effects of drugs and ultrasound // Ultrasonics Sonochem. – 2004. – Vol. 11. – P. 349–363.Rosenthal I., Sostaric J.Z., Riesz P. Sonodynamic therapy – a review of the synergistic effects of drugs and ultrasound, Ultrasonics Sonochem., 2004, vol. 11, pp. 349–363.Yumita Т., Nishigaki T., Umemura K., Umemura S.-I. Synergetic effect of ultrasound and hematoporphyrin on sarcoma 180 // J. Jpn. Cancer Res. – Vol. 81. – 1990. – P. 304.Yumita Т., Nishigaki T., Umemura K., Umemura S.-I. Synergetic effect of ultrasound and hematoporphyrin on sarcoma 180, J. Jpn. Cancer Res., vol. 81, 1990, p. 304.McHale A.P., Callan J.F., Nomikou N., et al. Sonodynamic therapy: concept, mechanism and application to cancer treatment // Adv. Exp. Med. Biol. – 2016. – Vol. 880. – P. 429–450.McHale A.P., Callan J.F., Nomikou N., Fowley C., Callan B. Sonodynamic therapy: concept, mechanism and application to cancer treatment, Adv. Exp. Med. Biol., 2016, vol. 880, pp. 429–450.Xiong W., Wang P., Hu J., et al. A new sensitizer DVDMS combined with multiple focused ultrasound treatments: an effective antitumor strategy // Sci. Rep. – 2015. – Vol. 5. – e17485.Xiong W., Wang P., Hu J., Jia Y., Wu L., Chen X., Liu Q., Wang X. A new sensitizer DVDMS combined with multiple focused ultrasound treatments: an effective antitumor strategy, Sci. Rep., 2015, vol. 5, e17485.Sun H., Ge W., Gao X., et al. Apoptosis-promoting effects of hematoporphyrin monomethyl ether-sonodynamic therapy (HMME-SDT) on endometrial cancer // PLoS One. – 2015. – Vol. 10, No. 9. – e0137980.Sun H., Ge W., Gao X., Wang S., Jiang S., Hu Y., Yu M., Hu S. Apoptosis-promoting effects of hematoporphyrin monomethyl ethersonodynamic therapy (HMME-SDT) on endometrial cancer, PLoS One, 2015, vol. 10, no. 9, e0137980.Li Y.N., Zhou Q., Yang B., et al. Mechanism of rat osteosarcoma cell apoptosis induced by a combination of low-intensity ultrasound and 5-aminolevulinic acid in vitro // Genet. Mol. Res. – 2015. – Vol. 14, No. 3. – P. 9604–9613.Li Y.N., Zhou Q., Yang B., Hu Z., Wang J.H., Li Q.S., Cao W.W. Mechanism of rat osteosarcoma cell apoptosis induced by a combination of low-intensity ultrasound and 5-aminolevulinic acid in vitro, Genet. Mol. Res., 2015, vol. 14, no. 3, pp. 9604–9613.Hu Z., Fan H., Lu G., et al. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis // J. Dermatol. Sci. – 2015. – Vol. 79, No. 2. – P. 155–162.Hu Z., Fan H., Lu G., Zhou Q., Yang B., Zheng J., Cao W. 5-Aminolevulinic acid-mediated sonodynamic therapy induces antitumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis, J. Dermatol. Sci., 2015, vol. 79, no. 2, pp. 155–162.Liu X., Li W., Geng S., et al. Apoptosis induced by sonodynamic therapy in human osteosarcoma cells in vitro // Mol. Med. Rep. – 2015. – Vol. 12, No. 1. – P. 1183–1188.Liu X., Li W., Geng S., Meng Q.G., Bi Z.G. Apoptosis induced by sonodynamic therapy in human osteosarcoma cells in vitro, Mol. Med. Rep., 2015, vol. 12, no. 1, pp. 1183–1188.Wang X.J., Luo J., Leung A.W., et al. Hypocrellin B in hepatocellular carcinoma cells: Subcellular localization and sonodynamic damage // Int. J. Radiat. Biol. – 2015. – Vol. 91, No. 5. – P. 399–406.Wang X.J., Luo J., Leung A.W., Li Y., Zhang H., Xu C. Hypocrellin B in hepatocellular carcinoma cells: Subcellular localization and sonodynamic damage, Int. J. Radiat. Biol., 2015, vol. 91, no. 5, pp. 399–406.Xiang J., Leung A.W., Xu C. Effect of ultrasound sonication on clonogenic survival and mitochondria of ovarian cancer cells in the presence of methylene blue // J. Ultrasound Med. – 2014. – Vol. 33, No. 10. – P. 1755–1761.Xiang J., Leung A.W., Xu C. Effect of ultrasound sonication on clonogenic survival and mitochondria of ovarian cancer cells in the presence of methylene blue, J. Ultrasound Med., 2014, vol. 33, no. 10, pp. 1755–1761.Dai S., Xu C.Q., Tien Y., et al. In vitro stimulation of calcium overload and apoptosis by sonodynamic therapy combined with hematoporphyrin monomethyl ether in C6 glioma cells // Oncol. Lett. – 2014. – Vol. 8, No. 4. – P. 1675–1681.Dai S., Xu C.Q., Tien Y., Cheng W., Li B. In vitro stimulation of calcium overload and apoptosis by sonodynamic therapy combined with hematoporphyrin monomethyl ether in C6 glioma cells, Oncol. Lett., 2014, vol. 8, no. 4, pp. 1675–1681.Li Y.J., Huang P., Jiang C.L., et al. Sonodynamically induced antitumor effect of 5-aminolevulinic acid on pancreatic cancer cells // Ultrasound Med. Biol. – 2014. – Vol. 40, No. 11. – P. 2671–2679.Li Y.J., Huang P., Jiang C.L., Jia de X., Du X.X., Zhou J.H., Han Y., Sui H., Wei X.L., Liu L., Yuan H.H., Zhang T.T., Zhang W.J., Xie R., Lang X.H., Wang L.Y., Liu T., Bai Y.X., Tian Y. Sonodynamically induced anti-tumor effect of 5-aminolevulinic acid on pancreatic cancer cells, Ultrasound Med. Biol., 2014, vol. 40, no. 11, pp. 2671–2679.Su X., Li Y., Wang P., et al. Protoporphyrin IX-mediated sonodynamic action induces apoptosis of K562 cells // Ultrasonics. – 2014. – Vol. 54. – P. 275–284.Su X., Li Y., Wang P., Wang X., Liu Q. Protoporphyrin IX-mediated sonodynamic action induces apoptosis of K562 cells, Ultrasonics, 2014, vol. 54, pp. 275–284.Chen B., Zheng R., Liu D., et al. The tumor affinity of chlorin e6 and its sonodynamic effects on non-small cell lung cancer // Ultrason. Sonochem. – 2013. – Vol. 20, No. 2. – P. 667–673.Chen B., Zheng R., Liu D., Li B., Lin J., Zhang W. The tumor affinity of chlorin e6 and its sonodynamic effects on non-small cell lung cancer, Ultrason. Sonochem., 2013, vol. 20, no. 2, pp. 667–673.Su X., Wang P., Wang X., et al. Apoptosis of U937 cells Induced by hematoporphyrin monomethyl ether-mediated sonodynamic action // Cancer Biother. Radiopharm. – 2013. – Vol. 28, No. 3. – P. 207–217.Su X., Wang P., Wang X., Cao B., Li L., Liu Q. Apoptosis of U937 cells Induced by hematoporphyrin monomethyl ether-mediated sonodynamic action, Cancer Biother. Radiopharm., 2013, vol. 28, no. 3, pp. 207–217.Foglietta F., Canaparo R., Francovich A., et al. Sonodynamic treatment as an innovative bimodal anticancer approach: shock wave-mediated tumor growth inhibition in a syngeneic breast cancer model // Discov. Med. – 2015. – Vol. 20, No. 110. – P. 197–205.Foglietta F., Canaparo R., Francovich A., Arena F., Civera S., Cravotto G., Frairia R., Serpe L. Sonodynamic treatment as an innovative bimodal anticancer approach: shock wave-mediated tumor growth inhibition in a syngeneic breast cancer model, Discov. Med., 2015, vol. 20, no. 110, pp. 197–205.Li Y., Zhou Q., Hu Z., et al. 5-Aminolevulinic acid-based sonodynamic therapy induces the apoptosis of osteosarcoma in mice // PLoS One. – 2015. – Vol. 10, No. 7. – e0132074.Li Y., Zhou Q., Hu Z., Yang B., Li Q., Wang J., Zheng J., Cao W. 5-Aminolevulinic acid-based sonodynamic therapy induces the apoptosis of osteosarcoma in mice, PLoS One., 2015, vol. 10, no. 7, e0132074.Alamolhoda M., Mokhtari-Dizaji M. Evaluation of fractionated and repeated sonodynamic therapy by using dual frequency for murine model of breast adenocarcinoma // J. Ther. Ultrasound. – 2015. – Vol. 3. – P. 10.Alamolhoda M., Mokhtari-Dizaji M. Evaluation of fractionated and repeated sonodynamic therapy by using dual frequency for murine model of breast adenocarcinoma, J. Ther. Ultrasound, 2015, vol. 3, p. 10.Hu Z., Fan H., Lu G., et al. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis // J. Dermatol. Sci. – 2015. – Vol. 79, No. 2. – P. 155–162.Hu Z., Fan H., Lu G., Zhou Q., Yang B., Zheng J., Cao W. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis, J.Dermatol. Sci., 2015, vol. 79, no. 2, pp. 155–162.Song D., Yue W., Li Z., et al. Study of the mechanism of sonodynamic therapy in a rat glioma model // Onco Targets Ther. – 2014. – Vol. 7. – P. 1801–1810.Song D., Yue W., Li Z., Li J., Zhao J., Zhang N. Study of the mechanism of sonodynamic therapy in a rat glioma model, Onco Targets Ther., 2014, vol. 7, pp. 1801–1810.Li C., Zhang K., Wang P., et al. Sonodynamic antitumor effect of a novel sonosensitizer on S180 solid tumor // Biopharm. Drug Dispos. – 2014. – Vol. 35, No. 1. – P. 50–59.Li C., Zhang K., Wang P., Hu J., Liu Q., Wang X. Sonodynamic antitumor effect of a novel sonosensitizer on S180 solid tumor, Biopharm. Drug Dispos., 2014, vol. 35, no. 1, pp. 50–59.Wang S., Hu Z., Wang X., et al. 5-Aminolevulinic acid-mediated sonodynamic therapy reverses macrophage and dendritic cell passivity in murine melanoma xenografts // Ultrasound Med. Biol. – 2014. – Vol. 40, No. 9. – P. 2125–2133.Wang S., Hu Z., Wang X., Gu C., Gao Z., Cao W., Zheng J. 5-Aminolevulinic acid-mediated sonodynamic therapy reverses macrophage and dendritic cell passivity in murine melanoma xenografts, Ultrasound Med. Biol., 2014, vol. 40, no. 9, pp. 2125–2133.Gao Z., Zheng J., Yang B., et al. Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model // Cancer Lett. – 2013. – Vol. 335. – P. 93–99.Gao Z., Zheng J., Yang B., Wang Z., Fan H., Lv Y., Li H., Jia L., Cao W. Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model, Cancer Lett., 2013, vol. 335, pp. 93–99.Chen B., Zheng R., Liu D., et al. The tumor affinity of chlorin e6 and its sonodynamic effects on non-small cell lung cancer // Ultrason. Sonochem. – 2013. – Vol. 20, No. 2. – P. 667–673.Chen B., Zheng R., Liu D., Li B., Lin J., Zhang W. The tumor affinity of chlorin e6 and its sonodynamic effects on non-small cell lung cancer, Ultrason. Sonochem., 2013, vol. 20, no. 2, pp. 667–673.Yamaguchi S., Endo S., Kudo N., et al. Porphyrin derivatesmediated sonodynamic therapy for malignant gliomas in vitro // Ultrasound Med. Biol. – 2015. – Vol. 41, No. 9. – P. 2458–2465.Yamaguchi S., Endo S., Kudo N., Sumiyoshi K., Motegi H., Kobayashi H., Terasaka S., Houkin K. Porphyrin derivates-mediated sonodynamic therapy for malignant gliomas in vitro, Ultrasound Med. Biol., 2015, vol. 41, no. 9, pp. 2458–2465.Церковский Д.А. Соно-фотодинамическая терапия – новое направление в лечении злокачественных опухолей головного мозга // Онколог. журн. – 2015. – Т. 9, № 1. – С. 94–106.Tserkovsky D.A. Sono-photodynamic therapy – a new direction in the treatment of malignant brain tumors, Oncolog. Jurn., 2015, vol. 9, no. 1, pp. 94–106.Kenyon J.N., Fulle R.J., Lewis T.J. Activated cancer therapy using light and ultrasound – a case series of sonodynamic photodynamic therapy in 115 patients over a 4 year period // Current Drug. Ther. – 2009. – Vol. 4. – P. 179–193.Kenyon J.N., Fulle R.J., Lewis T.J. Activated cancer therapy using light and ultrasound – a case series of sonodynamic photodynamic therapy in 115 patients over a 4 year period, Current Drug. Ther., 2009, vol. 4, pp. 179–193.Rengeng L., Qianyu Z., Yuehong L., et al. Sonodynamic therapy, a treatment developing from photodynamic therapy // Photodiagnosis Photodyn. Ther. – 2017. – Vol. 19. – P. 159–166.Rengeng L., Qianyu Z., Yuehong L., Zhongzhong P., Libo L. Sonodynamic therapy, a treatment developing from photodynamic therapy, Photodiagnosis Photodyn. Ther., 2017, vol. 19, pp. 159–166.Bakhshizadeh M., Moshirian T., Esmaily H., et al. Sonophotodyn amic therapy mediated by liposomal zinc phthalocyanine in a colon carcinoma tumor model: Role of irradiating arrangement // Iran J. Basic Med. Sci. – 2017. – Vol. 20, No. 10. – P. 1088–1092.Bakhshizadeh M., Moshirian T., Esmaily H., Rajabi O., Nassirli H., Sazgarnia A. Sonophotodynamic therapy mediated by liposomal zinc phthalocyanine in a colon carcinoma tumor model: Role of irradiating arrangement, Iran J. Basic Med. Sci., 2017, vol. 20, no. 10, pp. 1088–1092.Wang P., Li C., Wang X., et al. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo // Ultrasonics Sonochem. – 2015. – Vol. 23. – P. 116–127.Wang P., Li C., Wang X., Xiong W., Feng X., Liu Q., Leung A.W., Xu C. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo, Ultrasonics Sonochem., 2015, vol. 23, pp. 116–127.Tomankova K., Kolarova H., Vachutka J., et al. Study of photodynamic, sonodynamic and antioxidative influence on HeLa cell line // Ind. J. Biochem. Biophys. – 2014. – Vol. 51. – P. 19–28.Tomankova K., Kolarova H., Vachutka J., Zapletalova J., Hanakova A., Kaplova E. Study of photodynamic, sonodynamic and antioxidative influence on HeLa cell line, Ind. J. Biochem. Biophys., 2014, vol. 51, pp. 19–28.Li Q., Wang X., Wang P., et al. Efficacy of chlorin e6-mediated sono-photodynamic therapy on 4T1 cells // Cancer Biother. Radiopharmac. – 2014. – Vol. 29, No. 1. – P. 42–52.Li Q., Wang X., Wang P., Zhang K., Wang H., Feng X., Liu Q. Efficacy of chlorin e6-mediated sono-photodynamic therapy on 4T1 cells, Cancer Biother. Radiopharmac., 2014, vol. 29, no. 1, pp. 42–52.Wang H., Wang X., Wang P., et al.Ultrasound enhances the efficacy of chlorin e6-mediated photodynamic therapy in MDA-MB-231 cells // Ultrasound Med. Biol. – 2013. – Vol. 39, No. 9. – P. 1713–1724.Wang H., Wang X., Wang P., Zhang K., Yang S., Liu Q. Ultrasound enhances the efficacy of chlorin e6-mediated photodynamic therapy in MDA-MB-231 cells, Ultrasound Med. Biol., 2013, vol. 39, no. 9, pp. 1713–1724.Li J.H., Chen Z.Q., Huang Z., et al. In vitro study of low intensity ultrasound combined with different doses of PDT: effects on C6 glioma cells // Oncol. Lett. – 2013. – Vol. 5, No. 2. – P. 702–706.Li J. H., Chen Z. Q., Huang Z., Zhan Q., Ren F.B., Liu J.Y., Yue W., Wang Z. In vitro study of low intensity ultrasound combined with different doses of PDT: effects on C6 glioma cells, Oncol. Lett., 2013, vol. 5, no. 2, pp. 702–706.Церковский Д.А., Грачев Ю.Н., Артемьева Т.П., Истомин Ю.П. Соно-фотодинамическая терапия с фотолоном рецидивной формы мультиформной глиобластомы Grade IV: предварительные результаты I фазы клинического исследования // Фотодинамическая терапия и фотодиагностика. – 2015. – № 1. – С. 32–33.Tzerkovsky D., Grachev Yu., Artsemyeva T., Istomin Yu. Sono-photodynamic therapy with a photolon of the recurrent form of the Grade IV glioblastoma multiforme: preliminary results of the first phase of a clinical study, Fotodinamicheskaya terapiya i fotodiagnostika, 2015, vol. 4, no. 1, pp. 32–33.Tserkovsky D.A., Alexandrova E.N., Chalau V.N., Istomin Y.P. Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model // Exp. Oncol. – 2012. – Vol. 34, No. 4. – P. 332–335.Tserkovsky D. A., Alexandrova E. N., Chalau V.N., Istomin Y.P. Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model, Exp. Oncol., 2012, vol. 34, no. 4, pp. 332–335.Abder-Kader M.H. Photodynamic therapy. From theory to application. – Verlag, Berlin, Heidelberg: Springer, 2014. – 317 p.Abder-Kader M.H. Photodynamic therapy. From theory to application. Verlag, Berlin, Heidelberg, Springer, 2014. 317 p.Gomer C.J. Photodynamic therapy. Methods and protocols. – New York : Humana Press, 2010. – 299 p.Gomer C.J. Photodynamic therapy. Methods and protocols. New York, Humana Press, 2010. 299 p.Rapozzi V. and Jori G. Resistance to photodynamic therapy in cancer. – Switzerland: Springer, 2015. – 251 p.Rapozzi V. and Jori G. Resistance to photodynamic therapy in cancer. Switzerland, Springer, 2015. 251 p.Couture O., Foley J., Kassel N.F., et al. Review of ultrasound mediated drug delivery for cancer treatment: updates from pre-clinical studies // Transl. Cancer Res. – 2014. – Vol. 3, No. 5. – P. 494–511.Couture O., Foley J., Kassel N.F., Larrat B., Aubry J.-F.Review of ultrasound mediated drug delivery for cancer treatment: updates from pre-clinical studies, Transl. Cancer Res., 2014, vol. 3, no. 5, pp. 494–511.Huang Z., Moseley H., Bown S. Rationale of combined PDT and SDT modalities for treating cancer patients in terminal stage: the proper use of photosensitizer / // Integr. Cancer Ther. – 2010. – Vol. 9, No. 4. – P. 317–319.Huang Z., Moseley H., Bown S. Rationale of combined PDT and SDT modalities for treating cancer patients in terminal stage: the proper use of photosensitizer, Integr. Cancer Ther., 2010, vol. 9, no. 4. pp. 317–319.Inui T., Makita K., Miura H., et al. Case report: a breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy // Anticancer Res. – 2014. – Vol. 34. – P. 4589–4594.Inui T., Makita K., Miura H., Matsuda A., Kuchiike D., Kubo K., Mette M., Uto Y., Nishikata T., Hori H., Sakamoto N. Case report: a breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy, Anticancer Res., 2014, vol. 34, pp. 4589–4594.Li L.Q., Wang X., Zhang I.W., Mitchell D. Primary clinical use of the sono-photo-dynamic therapy for advanced esophagocadiac and gastric adenocarcinoma // J. Clin. Oncol. : Abstracts ASCO Annual Meeting, 2014. – Vol. 32 (Suppl.) – e15024.Li L.Q., Wang X., Zhang I.W., Mitchell D. Primary clinical use of the sono-photo-dynamic therapy for advanced esophagocadiac and gastric adenocarcinoma, J. Clin. Oncol., 2014, vol. 32 (suppl.), e15024.Wang X., Zhang W., Xu Z., et al. Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 cases // Integr. Cancer. Ther. – 2009. – Vol. 8, No. 3. – P. 283–287.Wang X., Zhang W., Xu Z., Luo Y., Mitchell D., Moss R.W. Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 cases, Integr. Cancer. Ther., 2009, vol. 8, no. 3, pp. 283–287.Wang X.J., Mitchell D., Lewis T.J. Primary clinical use of sonodynamic therapy (SDT) for advanced breast cancer // J. Clin. Oncol. – 2008. – Vol. 26, No. 15 (Suppl.). – Abstract 12029.Wang X.J., Mitchell D., Lewis T.J. Primary clinical use of sonodynamic therapy (SDT) for advanced breast cancer, J. Clin. Oncol., Abstracts ASCO Annual Meeting Proceedings, 2008, vol. 26, no. 15 (Suppl.), Abstract 12029.Murphy D., Meade B., Sali A. Prostate cancer treated by sonodynamic and photodynamic therapies (SPDT, NGPDT) // 66th Annual Meeting «USANZ 2013», Melbourne, 13–16 April, 2013. – Poster № 089.Murphy D., Meade B., Sali A. Prostate cancer treated by sonodynamic and photodynamic therapies (SPDT, NGPDT), in 66th Annual Meeting «USANZ 2013», Melbourne, 13–16 April, 2013. Poster № 089.Zhang W., Li K., Lu J., et al.Sonodynamic and photodynamic therapy in breast cancer: a pilot study // Int. J. Complement. Alt. Med. – 2017. – Vol. 9, No. 5. – P. 00313.Zhang W., Li K., Lu J., Peng Z., Wang X., Li Q., Zhao G., Hao J., Luo Y., Zhao Y., Yin X., O’Brien K.A. Sonodynamic and photodynamic therapy in breast cancer: a pilot study, Int. J. Complement. Alt. Med., 2017, vol. 9, no. 5, pp. 00313.Istomin Yu., Tzerkovsky D., Grachev Yu., et al. Intraoperative sonophotodynamic therapy with photolon in animal experiments and promising results of phase I clinical study in patients with recurrent malignant gliomas // J. Neuro-Oncol.– 2016. – Vol. 2, No. 2: 16. – P. 1–9.Istomin Yu., Tzerkovsky D., Grachev Yu., Artsemyeva T., Borichevsky F., Maslakov E., Semak I., Bagrintsev D. Intraoperative sono-photodynamic therapy with photolon in animal experiments and promising results of phase I clinical study in patients with recurrent malignant gliomas, J. Neuro-Oncol., 2016. vol. 2, no. 2, 16, pp. 1–9.

The authors declare that there are no conflicts of interest present.